Neovascularization is a compensatory process meant to restore oxygen homeostasis and promote recovery from hypoxic damage, and blocking the formation of new blood vessels may increase intra-tumor hypoxia, which is the rationale for anti-VEGF therapy in cancer patients. This evidence concerns the gene VEGFA and cancer.